{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:18:29Z","timestamp":1773836309834,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.cca.2017.07.013","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T20:00:29Z","timestamp":1500062429000},"page":"35-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["An LC-MS\/MS based candidate reference method for the quantification of carbamazepine in human serum"],"prefix":"10.1016","volume":"472","author":[{"given":"Judith","family":"Taibon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Lucha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Pongratz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirill","family":"Tarasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Seger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Timm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim Mark","family":"Herlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6137-6656","authenticated-orcid":false,"given":"Uwe","family":"Kobold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7234","key":"10.1016\/j.cca.2017.07.013_bb0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(62)91847-0","article-title":"Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883)","volume":"1","author":"Blom","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2017.07.013_bb0010","series-title":"Anticonvulsant Therapy: Pharmacological Basis and Practice","author":"Eadie","year":"1989"},{"issue":"2","key":"10.1016\/j.cca.2017.07.013_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-90-2-207","article-title":"The use of antiepileptic drugs","volume":"90","author":"Penry","year":"1979","journal-title":"Ann. Intern. Med."},{"issue":"21","key":"10.1016\/j.cca.2017.07.013_bb0020","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199011223232107","article-title":"The evaluation and treatment of seizures","volume":"323","author":"Scheuer","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cca.2017.07.013_bb0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2165\/00003088-198510010-00004","article-title":"Carbamazepine metabolism in man. Induction and pharmacogenetic aspects","volume":"10","author":"Eichelbaum","year":"1985","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cca.2017.07.013_bb0030","series-title":"Antiepileptic Drug Interactions: A Clinical Guide","author":"Patsalos","year":"2013"},{"issue":"1","key":"10.1016\/j.cca.2017.07.013_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2125.1991.tb03858.x","article-title":"Lack of enzyme induction with oxcarbazepine (600mg daily) in healthy subjects","volume":"31","author":"Larkin","year":"1991","journal-title":"Brit. J. Clin. Pharm."},{"issue":"11","key":"10.1016\/j.cca.2017.07.013_bb0040","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/dmd.30.11.1170","article-title":"Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites","volume":"30","author":"Pearce","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cca.2017.07.013_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2011.09.041","article-title":"Therapeutic drug monitoring and LC-MS\/MS","volume":"883\u2013884","author":"Adaway","year":"2012","journal-title":"J. Chromatogr. B"},{"issue":"1\u20132","key":"10.1016\/j.cca.2017.07.013_bb0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jchromb.2005.09.019","article-title":"Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma","volume":"828","author":"Breton","year":"2005","journal-title":"J. Chromatogr. B"},{"issue":"8","key":"10.1016\/j.cca.2017.07.013_bb0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jat\/bku070","article-title":"Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases","volume":"38","author":"Deeb","year":"2014","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.cca.2017.07.013_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00216-012-6481-x","article-title":"Analysis of carbamazepine and its five metabolites in serum by large-volume sample stacking-sweeping capillary electrophoresis","volume":"405","author":"Lin","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.cca.2017.07.013_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jchromb.2014.09.010","article-title":"Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine-10,11-epoxide and licarbazepine","volume":"971","author":"Ferreira","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.cca.2017.07.013_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.talanta.2016.05.036","article-title":"Development, validation and clinical application of an online-SPE-LC-HRMS\/MS for simultaneous quantification of phenobarbital, phenytoin, carbamazepine, and its active metabolite carbamazepine 10,11-epoxide","volume":"158","author":"Qu","year":"2016","journal-title":"Talanta"},{"issue":"4","key":"10.1016\/j.cca.2017.07.013_bb0075","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpba.2011.07.019","article-title":"Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"56","author":"Kim","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.cca.2017.07.013_bb0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jchromb.2007.10.025","article-title":"Development and validation of a LC\/MS\/MS method for simultaneous quantification of oxcarbazepine and its main metabolites in human serum","volume":"860","author":"Paglia","year":"2007","journal-title":"J. Chromatogr. B"},{"issue":"1\u20132","key":"10.1016\/j.cca.2017.07.013_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-2670(02)00980-7","article-title":"Simultaneous analysis of six antiepileptic drugs and two selected metabolites in human plasma by liquid chromatography after solid-phase extraction","volume":"472","author":"Bugamelli","year":"2002","journal-title":"Anal. Chim. Acta"},{"issue":"2","key":"10.1016\/j.cca.2017.07.013_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-4347(01)00328-0","article-title":"Simultaneous high-performance liquid chromatography determination of carbamazepine and five of its metabolites in plasma of epileptic patients","volume":"762","author":"Mandrioli","year":"2001","journal-title":"J. Chromatogr. B"},{"issue":"6","key":"10.1016\/j.cca.2017.07.013_bb0095","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1373\/clinchem.2008.107052","article-title":"Traceability in laboratory medicine","volume":"55","author":"Vesper","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2017.07.013_bb0100","author":"ICH"},{"key":"10.1016\/j.cca.2017.07.013_bb0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cca.2016.11.029","article-title":"An LC-MS\/MS based candidate reference method for the quantification of total gentamicin in human serum and plasma using NMR characterized calibrator material","volume":"464","author":"Lucha","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"13","key":"10.1016\/j.cca.2017.07.013_bb0110","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2017.07.013_bb0115","author":"JCGM"},{"issue":"4","key":"10.1016\/j.cca.2017.07.013_bb0120","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1515\/CCLM.2005.072","article-title":"Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry","volume":"43","author":"Vogeser","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.cca.2017.07.013_bb0125","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00007691-200112000-00021","article-title":"Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum","volume":"23","author":"Vogeser","year":"2001","journal-title":"Ther. Drug Monit."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117302632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117302632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T02:52:35Z","timestamp":1535597555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117302632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":25,"alternative-id":["S0009898117302632"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.07.013","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An LC-MS\/MS based candidate reference method for the quantification of carbamazepine in human serum","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}